Morningstar

Rydex Biotechnology Fund Class C RYCFX

Morningstar Medalist Rating
Unlock
Medalist Rating as of See Rydex Investment Hub
  • NAV / 1-Day Return $55.12  /  +2.09 %
  • Fund Size $157.6M
  • Adjusted Expense Ratio 2.380%
  • Net Expense Ratio 2.380%
  • Fee Level: Distribution High
  • Share Class Type Level Load
  • Morningstar Category Health
  • Equity Style Box (Funds) Mid Blend
  • Minimum Initial Investment $2,500
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 75%
NAV and 1-Day Return as of

Morningstar’s Analysis RYCFX

Will RYCFX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable RYCFX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the RYCFX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of RYCFX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Rydex Biotechnology C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RYCFX

More RYCFX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 40.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

7.88 10M
Healthcare

Amgen Inc

5.67 8M
Healthcare

Gilead Sciences Inc

4.93 7M
Healthcare

Vertex Pharmaceuticals Inc

4.48 6M
Healthcare

Moderna Inc

4.08 5M
Healthcare

Regeneron Pharmaceuticals Inc

3.56 5M
Healthcare

BeOne Medicines Ltd ADR

2.59 3M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.58 3M
Healthcare

Natera Inc

2.38 3M
Healthcare

Illumina Inc

2.23 3M
Healthcare

Sponsor Center